JUSTIN SUK JOO MOON
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- LONE TREE, CO
- NPI
- 1215019609
- Received
- $1,358,294 in 4,370 records, 2019 to 2025
- As principal investigator
- $36,319 of research payments to others in 8 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 656 | $233,150 |
| 2024 | General payment | 652 | $176,511 |
| 2023 | General payment | 603 | $133,275 |
| 2022 | General payment | 749 | $257,943 |
| 2021 | General payment | 690 | $237,673 |
| 2020 | General payment | 492 | $179,055 |
| 2019 | General payment | 528 | $140,684 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 468 | $879,992 |
| Honoraria | 50 | $119,570 |
| Consulting Fee | 49 | $117,081 |
| Travel and Lodging | 583 | $115,043 |
| Food and Beverage | 3,171 | $80,079 |
| Compensation for serving as faculty or as a speaker for a medical education program | 22 | $46,052 |
| Education | 25 | $386 |
| Grant | 2 | $87 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-12-18 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-12-18 | JAZZ PHARMACEUTICALS INC. | $20 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-12-18 | PFIZER INC. | $9 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-18 | JAZZ PHARMACEUTICALS INC. | $2 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-12-17 | Biogen, Inc. | $24 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2025 | |
| 2025-12-16 | Lilly USA, LLC | $125 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-12-16 | Ipsen Biopharmaceuticals, Inc | $106 | Food and Beverage | In-kind items and services | Dysport Drug, Neurology | 2025 | |
| 2025-12-16 | Lilly USA, LLC | $90 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-12-16 | Lilly USA, LLC | $78 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-12-16 | ARGENX US, INC. | $32 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-12-16 | Lilly USA, LLC | $31 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-12-16 | Lilly USA, LLC | $30 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-12-16 | Genentech USA, Inc. | $28 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2025 | |
| 2025-12-16 | Lilly USA, LLC | $19 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-12-16 | Lilly USA, LLC | $17 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-12-16 | ARGENX US, INC. | $5 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-12-16 | Biogen, Inc. | $3 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2025 | |
| 2025-12-12 | Neurelis, Inc. | $37 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-12-12 | CSL Behring | $12 | Food and Beverage | In-kind items and services | Hizentra Biological, Immunology | 2025 | |
| 2025-12-11 | TG Therapeutics, Inc. | $39 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-12-10 | EMD Serono, Inc. | $22 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-12-10 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-12-10 | PFIZER INC. | $5 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-12-09 | Axsome Therapeutics, Inc. | $3,038 | Honoraria | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-09 | Axsome Therapeutics, Inc. | $121 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-12-09 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-12-09 | Celgene Corporation | $23 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-12-09 | Axsome Therapeutics, Inc. | $21 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-08 | Lilly USA, LLC | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-12-08 | Lilly USA, LLC | $875 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-12-06 | PFIZER INC. | $19 | Food and Beverage | In-kind items and services | PANZYGA Biological, IMMUNOLOGY;INFLAMMATION | 2025 | |
| 2025-12-04 | SK Life Science, Inc. | $21 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-03 | Axsome Therapeutics, Inc. | $4,725 | Honoraria | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $3,038 | Honoraria | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Eisai Inc. | $1,600 | Consulting Fee | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $446 | Travel and Lodging | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $386 | Travel and Lodging | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $130 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $109 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $88 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $49 | Food and Beverage | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $31 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $29 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $28 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $26 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $11 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $11 | Travel and Lodging | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-03 | Axsome Therapeutics, Inc. | $7 | Food and Beverage | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-12-02 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-12-01 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-27 | LivaNova USA, Inc. | $36 | Food and Beverage | In-kind items and services | VNS Therapy Device, Neurology | 2025 | |
| 2025-11-25 | Lilly USA, LLC | $1,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-25 | JAZZ PHARMACEUTICALS INC. | $20 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-11-24 | Eisai Inc. | $7 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-11-22 | CSL Behring | $26 | Food and Beverage | In-kind items and services | Hizentra Biological, Immunology | 2025 | |
| 2025-11-21 | PFIZER INC. | $6 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-20 | EMD Serono, Inc. | $39 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-11-20 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-20 | PFIZER INC. | $14 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-19 | Genentech USA, Inc. | $29 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2025 | |
| 2025-11-19 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-19 | Axsome Therapeutics, Inc. | $6 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-11-18 | PFIZER INC. | $23 | Food and Beverage | In-kind items and services | PANZYGA Biological, IMMUNOLOGY;INFLAMMATION | 2025 | |
| 2025-11-18 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-11-18 | PFIZER INC. | $3 | Food and Beverage | In-kind items and services | PANZYGA Biological, IMMUNOLOGY;INFLAMMATION | 2025 | |
| 2025-11-17 | Lilly USA, LLC | $1,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-14 | Biogen, Inc. | $23 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2025 | |
| 2025-11-13 | Tonix Medicines, Inc. | $22 | Food and Beverage | In-kind items and services | ZEMBRACE SYMTOUCH Drug, NEUROLOGY | 2025 | |
| 2025-11-13 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-11-13 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-11-13 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-11-12 | Lilly USA, LLC | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-12 | Lilly USA, LLC | $2,025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-12 | ARGENX US, INC. | $31 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-11-11 | Eisai Inc. | $23 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-11-10 | Lilly USA, LLC | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-10 | Lilly USA, LLC | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-10 | Lilly USA, LLC | $2,025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-11-10 | Novartis Pharmaceuticals Corporation | $28 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-11-07 | Eisai Inc. | $337 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-07 | Neurelis, Inc. | $31 | Food and Beverage | In-kind items and services | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-11-07 | Alexion Pharmaceuticals, Inc. | $22 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2025 | |
| 2025-11-06 | Lilly USA, LLC | $580 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-11-05 | Eisai Inc. | $239 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-11-05 | Celgene Corporation | $15 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-11-04 | Vanda Pharmaceuticals Inc. | $26 | Food and Beverage | In-kind items and services | PONVORY Drug, MULTIPLE SCLEROSIS | 2025 | |
| 2025-11-03 | Lilly USA, LLC | $1,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-03 | Biogen, Inc. | $22 | Food and Beverage | In-kind items and services | SKYCLARYS Drug, Neurology | 2025 | |
| 2025-11-03 | PFIZER INC. | $9 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-31 | Lilly USA, LLC | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-31 | Lilly USA, LLC | $2,025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-31 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | PANZYGA Biological, IMMUNOLOGY;INFLAMMATION | 2025 | |
| 2025-10-31 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | PANZYGA Biological, IMMUNOLOGY;INFLAMMATION | 2025 | |
| 2025-10-31 | Novartis Pharmaceuticals Corporation | $3 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-10-29 | Eisai Inc. | $823 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-10-29 | Eisai Inc. | $823 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-10-29 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-10-28 | Janssen Biotech, Inc. | $24 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-28 | Cycle Pharmaceuticals Inc | $13 | Food and Beverage | Cash or cash equivalent | Bafiertam Drug, Neurology | 2025 | |
| 2025-10-27 | CSL Behring | $11 | Food and Beverage | In-kind items and services | Hizentra Biological, Immunology | 2025 | |
| 2025-10-27 | PFIZER INC. | $3 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-26 | PFIZER INC. | $10 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-24 | Lilly USA, LLC | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-24 | Eisai Inc. | $171 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-10-24 | UCB, Inc. | $31 | Food and Beverage | In-kind items and services | Nayzilam Drug, Neurology | 2025 | |
| 2025-10-24 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-23 | Eisai Inc. | $3,200 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-10-23 | Eisai Inc. | $1,600 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-10-23 | Eisai Inc. | $1,600 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-10-23 | Eisai Inc. | $640 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-10-23 | Eisai Inc. | $223 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-10-23 | Eisai Inc. | $101 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-10-23 | Eisai Inc. | $72 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-10-23 | Eisai Inc. | $31 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-10-23 | Biogen, Inc. | $28 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2025 | |
| 2025-10-22 | Lilly USA, LLC | $713 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-10-22 | Lilly USA, LLC | $157 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-10-22 | EMD Serono, Inc. | $25 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-10-21 | SK Life Science, Inc. | $28 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-21 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-10-20 | Neurocrine BioSciences, Inc. | $40 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-20 | PFIZER INC. | $5 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-16 | Lilly USA, LLC | $179 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-10-16 | Lilly USA, LLC | $42 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-10-16 | Lilly USA, LLC | $39 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-10-16 | Lilly USA, LLC | $35 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-10-16 | Lilly USA, LLC | $25 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-10-16 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-15 | ARGENX US, INC. | $34 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-10-15 | Genentech USA, Inc. | $33 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2025 | |
| 2025-10-15 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-15 | Tonix Medicines, Inc. | $8 | Food and Beverage | In-kind items and services | ZEMBRACE SYMTOUCH Drug, NEUROLOGY | 2025 | |
| 2025-10-14 | JAZZ PHARMACEUTICALS INC. | $22 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-10-14 | JAZZ PHARMACEUTICALS INC. | $2 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-10-13 | Novartis Pharmaceuticals Corporation | $24 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-10-10 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-10-09 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-10-08 | PFIZER INC. | $226 | Travel and Lodging | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-10-08 | PFIZER INC. | $217 | Travel and Lodging | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-10-08 | PFIZER INC. | $145 | Travel and Lodging | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-10-08 | PFIZER INC. | $100 | Food and Beverage | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-10-08 | PFIZER INC. | $95 | Travel and Lodging | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-10-08 | PFIZER INC. | $71 | Food and Beverage | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-10-08 | Axsome Therapeutics, Inc. | $31 | Food and Beverage | In-kind items and services | Symbravo Drug, Neurology | 2025 | |
| 2025-10-07 | Eisai Inc. | $31 | Food and Beverage | In-kind items and services | Leqembi Drug, Neurology | 2025 | |
| 2025-10-06 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-10-06 | Celgene Corporation | $15 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-10-06 | CSL Behring | $8 | Food and Beverage | In-kind items and services | Hizentra Biological, Immunology | 2025 | |
| 2025-10-02 | Neurocrine BioSciences, Inc. | $33 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-02 | Vanda Pharmaceuticals Inc. | $20 | Food and Beverage | In-kind items and services | PONVORY Drug, MULTIPLE SCLEROSIS | 2025 | |
| 2025-10-01 | PFIZER INC. | $42 | Travel and Lodging | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-30 | Lilly USA, LLC | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-09-30 | Lilly USA, LLC | $1,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-09-30 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-30 | TG Therapeutics, Inc. | $8 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-09-30 | TG Therapeutics, Inc. | $5 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-09-29 | PFIZER INC. | $20 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-29 | JAZZ PHARMACEUTICALS INC. | $10 | Food and Beverage | In-kind items and services | EPIDIOLEX Drug, NEUROLOGY | 2025 | |
| 2025-09-26 | PFIZER INC. | $4,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-26 | PFIZER INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-26 | PFIZER INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-26 | PFIZER INC. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-26 | PFIZER INC. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-26 | PFIZER INC. | $311 | Travel and Lodging | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-26 | PFIZER INC. | $6 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-26 | PFIZER INC. | $3 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-25 | ABBVIE INC. | $3,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-25 | Genentech USA, Inc. | $24 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2025 | |
| 2025-09-25 | UCB, Inc. | $21 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2025 | |
| 2025-09-25 | ABBVIE INC. | $9 | Education | In-kind items and services | BOTOX Biological, FACIAL AESTHETICS | 2025 | |
| 2025-09-25 | Genentech USA, Inc. | $2 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2025 | |
| 2025-09-25 | UCB, Inc. | $1 | Food and Beverage | In-kind items and services | Fintepla Drug, Neurology | 2025 | |
| 2025-09-24 | Eisai Inc. | $7,680 | Consulting Fee | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-09-24 | Eisai Inc. | $3,840 | Travel and Lodging | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-09-24 | Eisai Inc. | $78 | Food and Beverage | Cash or cash equivalent | Leqembi Drug, Neurology | 2025 | |
| 2025-09-24 | SK Life Science, Inc. | $29 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-23 | PFIZER INC. | $48 | Food and Beverage | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-23 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-23 | ACADIA Pharmaceuticals Inc | $17 | Food and Beverage | In-kind items and services | NUPLAZID Drug, PARKINSONS DISEASE PSYCHOSIS | 2025 | |
| 2025-09-22 | PFIZER INC. | $1,525 | Consulting Fee | Cash or cash equivalent | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-22 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | KESIMPTA Drug, Neurology | 2025 | |
| 2025-09-22 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | BOTOX Biological, BOTOX THERAPEUTIC | 2025 | |
| 2025-09-19 | Celgene Corporation | $16 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-09-18 | Lilly USA, LLC | $155 | Travel and Lodging | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-09-18 | Lilly USA, LLC | $120 | Food and Beverage | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-09-18 | PFIZER INC. | $90 | Food and Beverage | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-18 | Lilly USA, LLC | $35 | Food and Beverage | Cash or cash equivalent | KISUNLA Drug, Neuroscience | 2025 | |
| 2025-09-18 | PFIZER INC. | $34 | Food and Beverage | In-kind items and services | ZAVZPRET Drug, PAIN | 2025 | |
| 2025-09-18 | PFIZER INC. | $9 | Food and Beverage | In-kind items and services | NURTEC ODT Drug, PAIN | 2025 | |
| 2025-09-17 | Lilly USA, LLC | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-09-17 | Lilly USA, LLC | $2,025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-09-17 | Axsome Therapeutics, Inc. | $675 | Honoraria | Cash or cash equivalent | Symbravo Drug, Neurology | 2025 | |
| 2025-09-17 | ARGENX US, INC. | $26 | Food and Beverage | In-kind items and services | VYVGART HYTRULO Drug, Neurology | 2025 | |
| 2025-09-17 | Ipsen Biopharmaceuticals, Inc | $14 | Food and Beverage | In-kind items and services | Dysport Drug, Neurology | 2025 | |
| 2025-09-17 | Ipsen Biopharmaceuticals, Inc | $2 | Food and Beverage | In-kind items and services | Dysport Drug, Neurology | 2025 | |
| 2025-09-16 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-16 | ABBVIE INC. | $21 | Travel and Lodging | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2025 | |
| 2025-09-15 | Lilly USA, LLC | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-09-12 | Lilly USA, LLC | $2,300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 |
The latest 200 records of 4,370.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2021-03-24 | Amgen Inc. | DENVER NEUROLOGICAL CLINIC | $10,220 | Erenumab - Comprehensive Assessment of Efficacy (EMBRACE) | 2021 |
| 2021-01-04 | Amgen Inc. | DENVER NEUROLOGICAL CLINIC | $4,591 | Erenumab - Comprehensive Assessment of Efficacy (EMBRACE) | 2021 |
| 2020-12-22 | Amgen Inc. | DENVER NEUROLOGICAL CLINIC | $4,707 | Erenumab - Comprehensive Assessment of Efficacy (EMBRACE) | 2020 |
| 2020-11-09 | Amgen Inc. | DENVER NEUROLOGICAL CLINIC | $1,725 | Erenumab - Comprehensive Assessment of Efficacy (EMBRACE) | 2020 |
| 2019-05-15 | Teva Pharmaceuticals USA, Inc. | DENVER NEUROLOGICAL RESEARCH, LLC | $2,085 | Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Prev | 2019 |
| 2019-03-01 | Teva Pharmaceuticals USA, Inc. | DENVER NEUROLOGICAL RESEARCH, LLC | $831 | Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Prev | 2019 |
| 2019-01-29 | Allergan, Inc. | DENVER NEUROLOGICAL CLINICAL | $6,080 | A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SINGLE ATTACK STUDY TO EVALUATE THE EFFICACY, SAFETY | 2019 |
| 2019-01-29 | Allergan, Inc. | DENVER NEUROLOGICAL CLINICAL | $6,080 | A MULTICENTER, RANDOMIZED, OPEN LABEL EXTENSION STUDY TO EVALUATE THE LONG TERM SAFETY AND TOLOERABILITY OF ORAL UBROGE | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Lone Tree, CO, county Douglas County, CO, state Colorado; placed by its city name.
| Measure | Place (city or town) Lone Tree, CO | County Douglas County, CO | State Colorado |
|---|---|---|---|
| Population B01003 | 14,147 | 377,150 | 5,862,189 |
| Population, 2020 census P1 | 14,253 | 357,978 | 5,773,714 |
| Median age B01002 | 41.5 | 39.6 | 37.7 |
| Under 18 B01001 | 16.7% | 23.4% | 21.0% |
| 65 and over B01001 | 20.7% | 13.9% | 15.6% |
| Households B11001 | 6,507 | 139,960 | 2,374,218 |
| Foreign born B05002 | 14.6% | 8.4% | 9.8% |
| Median household income B19013 | $123,741 | $149,594 | $95,470 |
| Median family income B19113 | $161,761 | $171,592 | $119,139 |
| Per capita income B19301 | $80,752 | $69,608 | $52,636 |
| Poverty rate B17001 | 4.9% | 3.8% | 9.4% |
| Unemployment rate B23025 | 3.0% | 3.6% | 4.6% |
| Civilian labor force B23025 | 8,182 | 215,509 | 3,235,476 |
| Mean commute (minutes) B08013 | 25.7 | 27.1 | 25.2 |
| Bachelor's degree or higher B15003 | 71.2% | 62.0% | 45.7% |
| Housing units B25001 | 6,798 | 144,432 | 2,589,053 |
| Owner-occupied B25003 | 54.5% | 77.4% | 66.2% |
| Renters B25003 | 45.5% | 22.6% | 33.8% |
| Median home value B25077 | $874,100 | $713,600 | $539,400 |
| Median gross rent B25064 | $2,139 | $2,193 | $1,761 |
| White, not Hispanic B03002 | 74.5% | 77.0% | 64.8% |
| Black B03002 | 2.9% | 1.3% | 3.8% |
| Hispanic or Latino B03002 | 6.1% | 10.2% | 22.5% |
| Asian B03002 | 11.3% | 5.8% | 3.2% |
| American Indian and Alaska Native B03002 | 0.4% | 0.2% | 0.4% |
Economy now FRED unemployment 4.1% in Sep 2026 (3.8% a year earlier); per capita personal income $86,342 in 2025, up 34% in five years (+7.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Lone Tree, CO.
Comments